Bids Are Invited For Acquisition Of Pharmacological Medicines For The Palotina Sector Veterinary Hospital.

Acetylcysteine ​​Dosage: 100, Pharmaceutical Form: Acetylcysteine ​​Injectable Solution. Dosage: 100 Mg/Ml, Pharmaceutical Form: Injectable Solution, Amoxicillin Active Ingredient: Associated With Potassium Clavulanate, Concentration: 50 Mg/Ml + 12.5, Pharmaceutical Form: Oral Suspension Amoxicillin Active Ingredient: Associated With Potassium Clavulanate, Concentration: 50 Mg/Ml + 12.5 Mg/Ml, Pharmaceutical Form: Oral Suspension, Ampicillin Presentation: Associated With Sulbactam, Dosage: 1G + 500Mg, Type Of Use: Injectable Ampicillin. Presentation: Associated With Sulbactam, Dosage: 1G + 500Mg, Type Of Use: Injectable, Amphotericin B Dosage: 50, Application: Injectable Amphotericin B. Dosage: 50 Mg, Application: Injectable, Atropine Sulfate Dosage: 10, Use: Atropine Sulfate Ophthalmic Solution. Dosage: 10 Mg/Ml, Use: Ophthalmic Solution, Ceftazidime Concentration: 1, Pharmaceutical Form: Powder For Injectable Solution Ceftazidime Concentration: 1 G, Pharmaceutical Form: Powder For Injectable Solution, Ceftriaxone Sodium Concentration: 1, Pharmaceutical Form: Powder For Injectable Solution Ceftriaxone Sodium Concentration: 1G, Ciprofloxacin Hydrochloride Dosage: 3, Pharmaceutical Form: Ophthalmic Solution Ciprofloxacin Hydrochloride Dosage: 3, Pharmaceutical Form: Ophthalmic Solution, Ciprofloxacin Hydrochloride Composition: Associated With Dexamethasone, Concentration: 3.5 Mg + 1, Pharmaceutical Form: Ciprofloxacin Ophthalmic Suspension Hydrochloride Composition: Associated With Dexamethasone, Concentration: 3.5 Mg + 1 Mg/Ml, Pharmaceutical Form: Ophthalmic Suspension, Dexmedetomidine Hydrochloride Concentration: 100, Pharmaceutical Form: Injectable Solution Dexmedetomidine Hydrochloride Concentration: 100 Mcg/Ml, Dextran Composition: Dextran 70 Associated With Hypromellose, Concentration: 0.1% + 0.3%, Pharmaceutical Form: Dextran Ophthalmic Solution Composition: Dextran 70. Associated With Hypromellose, Concentration: 0, Phytomenadione Dosage: 10, Presentation: Phytomenadione Injectable Solution Dosage: 10 Mg/Ml, Presentation: Injectable Solution, Flumazenil Dosage: 0.1, Indication: Flumazenil Injectable Solution Dosage: 0.1 Mg/Ml, Indication: Injectable Solution, Heparin Sodium Dosage: 5,000Ui/Ml, Indication: Injectable Heparin Sodium Dosage: 5,000Ui/Ml, Indication: Injectable, Lactulose Concentration: 667, Pharmaceutical Form: Lactulose Syrup Concentration: 667 Mg/Ml, Pharmaceutical Form: Syrup, Methylprednisolone Active Ingredient: Acetate Salt, Dosage: 40, Pharmaceutical Form: Injectable Suspension Methylprednisolone Active Ingredient: Acetate Salt, Dosage: 40 Mg/Ml, Pharmaceutical Form: Suspension Injectable., Midazolam Dosage: 5, Application: Injectable Midazolam Dosage: 5 Mg/Ml, Morphine Presentation: Sulfate, Concentration: 10Mg/Ml, Pharmaceutical Form: Injectable Solution Morphine Presentation: Sulfate, Concentration: 10Mg/Ml, Naloxone Hydrochloride Dosage: 0, 4, Presentation: Injectable Solution Naloxone Hydrochloride Dosage: 0.4 Mg/Ml, Nystatin Dosage: 100,000 Iu/Ml, Presentation: Nystatin Oral Suspension Dosage: 100,000 Iu/Ml, Presentation: Oral Suspension, Oxybuprocaine Concentration: 4, Pharmaceutical Form: Oxybuprocaine Ophthalmic Solution Concentration: 4 Mg/Ml, Pethidine Hydrochloride Dosage: 50, Presentation: Injectable Solution Pethidine Hydrochloride Dosage: 50 Mg/Ml, Prednisolone Composition: Acetate, Concentration: 10, Pharmaceutical Form: Ophthalmic Suspension Prednisolone Composition: Acetate, Concentration: 10 Mg/Ml, Pharmaceutical Form: Suspension Ophthalmic, Prednisolone Composition: Sodium Phosphate, Pharmaceutical Form: Prednisolone Oral Solution Composition: Sodium Phosphate